Monashee Investment Management LLC Spring Works Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$18.94 - $37.24 $1.4 Million - $2.75 Million	73,949 New	73,949 $2.7 Million
Q4 2021 Feb 07, 2022	SELL	$53.3 - $75.84 $3.03 Million - $4.31 Million	-56,766 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$62.66 - $88.26 $737,257 - $1.04 Million	11,766 Added 26.15%	56,766 $3.6 Million
Q2 2021 Aug 12, 2021	BUY	$67.45 - $85.63 $674,500 - $856,300	10,000 Added 28.57%	45,000 $3.71 Million
Q1 2021 May 14, 2021	BUY	$65.1 - $93.59 $2.28 Million - $3.28 Million	35,000 New	35,000 $2.58 Million
Q4 2019 Feb 12, 2020	SELL	$17.74 - $39.52 $1.47 Million - $3.27 Million	-82,803 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$18.8 - $27.82 $1.56 Million - $2.3 Million	82,803 New	82,803 $1.8 Million

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.6B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.